• Andrei Nikiforchin MD

  • Associate Clinical Research Coordinator


    • MAR CL_MCRI-MCRI-Cancer Care and Research
    • 1000 North Oak Avenue Marsh Main > (30430) Mfd Main 3 Onc Marshfield, WI 54449

Education

2025 to Present:
MPH, Epidemiology, Harvard T.H Chan School of Public Health, Boston, MA, USA
2017 to 2018:
Residency, Surgical Oncology, Russian Medical Academy of Continuous Professional Education, Moscow, Russia
2016 to 2017:
Residency, Surgical Oncology, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia
2015 to 2016:
Residency, General Surgery, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia
2009 to 2015:
MD, Medicine, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia

Work Experience

2025 to Present:
Clinical Research Coordinator, Cancer Care and Research Center, Marshfield, WI, USA
2024 to Present:
Researcher, Global Medical Knowledge Alliance, Boston, MA, USA & Kyiv, Ukraine
2022 to 2026:
Clinical Expert - Surgical Oncology, Medical Solutions Foundation "Ne Naprasno", St. Petersburg, Russia
2022 to 2026:
Medical Writer/Editor, Medical Solutions Foundation "Ne Naprasno", St. Petersburg, Russia
2018 to 2023:
Postdoctoral Research Fellow, Mercy Medical Center, Baltimore, MD, USA
2018 to 2018:
General Surgeon, Clinical Hospital #1 MEDSI, Moscow, Russia

Honors & Awards

2022 to 2022:
2022 Society of Surgical Oncology / Appendix Cancer and Pseudomyxoma Peritonei Research Foundation Travel Award
2020 to 2020:
2020 Society of Surgical Oncology / Appendix Cancer and Pseudomyxoma Peritonei Research Foundation Travel Award
2018 to 2018:
European Society for Medical Oncology Preceptorship Program in Neuroendocrine Neoplasms
2017 to 2017:
11th European Digestive Surgery Postgraduate Course Grant
2017 to 2017:
United European Gastroenterology Evidence-Based Medicine Course Grant 2017

Research Interests

Cancer Care Access and Capacity, Public Health, Cancer Epidemiology, Biostatistics & Data Analysis, Peritoneal Surface Malignancies, HIPEC, Medical Education

Presentations

2024:
Utility of Left Lateral Liver Lobectomy in Removing Retrohepatic Lesions during Cytoreductive Surgery for Low-grade Mucinous Carcinomatosis, Lyon, France
2023:
Recurrence Patterns of Appendiceal Cancer after Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy, Boston, MA, USA
2023:
Recurrence Patterns of Appendiceal Cancer after Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy, San Diego, CA, USA
2022:
The Value of Surgical Collaboration during Cytoreductive Surgery for Advanced Ovarian Cancer, Baltimore, MD, USA
2022:
Association of Preoperative C-reactive protein with Survival in Different Histologies of Mucinous Appendiceal Cancer, Dallas, TX, USA
2022:
Safety of Nephrectomy Performed during CRS/HIPEC: A Propensity Score Matched Study, Dallas, TX, USA
2021:
Small Bowel Involvement Topography and Success of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancies, Rome, Italy
2021:
Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Carcinomatosis, SSO 2021 Virtual Meeting
2021:
Outcomes of Appendiceal Peritoneal Carcinomatosis Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, RARE 2021 Virtual Conference on Rare Diseases
2020:
Impact of Peritoneal Mucinous Deposit Cellularity on Survival in Patients with Low-grade Appendiceal Mucinous Neoplasm, Orlando, FL, USA

Select Publications

  • Levett JY, Nikiforchin A, de Angelis P, Lachapelle K, Kurth T. The Waitlist Matters, But So Does the Match: Reconsidering the HeartMate 3 Survival Advantage. JACC Heart Fail. 14(10):103350. doi: 10.1016/j.jchf.2026.103350.
    PubMed ID: 42833774
  • Karavska A, Kizub D, Kovalchuk N, Brovchuk S, Sokolovska M, Nikiforchin A, Melnitchouk N. Cancer care in wartime Ukraine: disruption, resilience and recovery. BMJ Oncol. 2026 February;5(1):e000943. doi: 10.1136/bmjonc-2025-000943. PMCID: PMC12933798.
    PubMed ID: 41757334
  • Baron E, Xu Z, Paro A, Nikiforchin A, Singh R, Wernberg JA, Sharma R. Robotic versus open cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score-matched study. Surg Endosc. 40(3):2304-2312. doi: 10.1007/s00464-025-12494-7.
    PubMed ID: 41444831
  • Lopez-Ramirez F, Uzhegova K, King MC, Falla-Zuniga LF, Nikiforchin A, Baron E,...Gushchin V. Controlling perfusion temperature relates to better outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 52(1):110536. doi: 10.1016/j.ejso.2025.110536.
    PubMed ID: 41237474
  • Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL,...Woo Y. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases. Ann Surg Oncol. 33(6):5222-5239. doi: 10.1245/s10434-025-17361-2. PMCID: 1243028.
    PubMed ID: 40560499
  • Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F,...PSM Consortium Group. Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Ann Surg Oncol. 2026 June;33(6):5142-5175. doi: 10.1245/s10434-025-17359-w. PMCID: 5343298.
    PubMed ID: 40560498
  • Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F,...PSM Consortium Group. Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement. Ann Surg Oncol. 2026 June;33(6):5176-5203. doi: 10.1245/s10434-025-17364-z. PMCID: 10249754.
    PubMed ID: 40560501
  • Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA, Wang JJ,...PSM Consortium Group. Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases. Ann Surg Oncol. 2026 June;33(6):5260-5282. doi: 10.1245/s10434-025-17363-0. PMCID: 6583775.
    PubMed ID: 40560497
  • Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK,...PSM Consortium Group. Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms. Ann Surg Oncol. 2026 June;33(6):5204-5221. doi: 10.1245/s10434-025-17360-3. PMCID: 9513765.
    PubMed ID: 40560496
  • Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK,...PSM Consortium Group. Consensus Guideline for the Management of Peritoneal Mesothelioma. Ann Surg Oncol. 2026 June;33(6):5125-5141. doi: 10.1245/s10434-025-17358-x. PMCID: 5497105.
    PubMed ID: 40560500
  • Antoniv M, Maldonado LJ, Nikiforchin A, Gershanik EF, Bleday R. Enhanced Recovery after Surgery Protocol Compliance and Early Outcomes for Elective Colorectal Procedures by Race/Ethnicity and Socioeconomic Status. Ann Surg. 284(1):148-156. doi: 10.1097/SLA.0000000000006622.
    PubMed ID: 39781757
  • Semeniv S, Antoniv M, Dzhemiliev A, Kochis M, Shabat G, Huivaniuk I,...Melnitchouk N. Education in Adversity: Enhancing Surgical Training Through the "Principles of Surgery" Course in Wartime Ukraine. World J Surg. 49(12):3410-3418. doi: 10.1002/wjs.70159.
    PubMed ID: 41266085
  • Hornik I, Nikiforchin A, Antoniv M, Huivaniuk I, Malovanna A, Dzhemiliev A,...Melnitchouk N. Enhancing Colonoscopy Quality: Evaluating Adherence to Performance Measures in Ukraine. JCO Glob Oncol. 11:e2500390. doi: 10.1200/GO-25-00390.
    PubMed ID: 41160779
  • Antoniv M, Huivaniuk I, Mark R, Strilka L, Kuryk M, Malovanna A,...Melnitchouk N. Impact of Representation on Gender Stereotypes and Discrimination for Women Surgeons in Ukraine. World J Surg. 49(9):2425-2435. doi: 10.1002/wjs.70010.
    PubMed ID: 40689746
  • Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL,...Woo Y. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer. 131(13):e35870. doi: 10.1002/cncr.35870.
    PubMed ID: 40558029
  • Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F,...PSM Consortium Group. Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement. Cancer. 2025 July 1;131(13):e35867. doi: 10.1002/cncr.35867.
    PubMed ID: 40558045
  • Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F,...PSM Consortium Group. Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Cancer. 2025 July 1;131(13):e35874. doi: 10.1002/cncr.35874.
    PubMed ID: 40558065
  • Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA, Wang JJ,...PSM Consortium Group. Consensus guideline for the management of colorectal cancer with peritoneal metastases. Cancer. 2025 July 1;131(13):e35869. doi: 10.1002/cncr.35869.
    PubMed ID: 40558054
  • Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK,...PSM Consortium Group. Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms. Cancer. 2025 July 1;131(13):e35871. doi: 10.1002/cncr.35871.
    PubMed ID: 40558053
  • Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK,...PSM Consortium Group. Consensus guideline for the management of peritoneal mesothelioma. Cancer. 2025 July 1;131(13):e35868. doi: 10.1002/cncr.35868.
    PubMed ID: 40558081
  • Nikiforchin A, Sardi A, King MC, Iugai S, Gushchin V. Utility of Left Lateral Liver Lobectomy in Removing Retrohepatic Lesions During Cytoreductive Surgery for Low-Grade Mucinous Carcinoma Peritonei. Ann Surg Oncol. 32(7):5083-5084. doi: 10.1245/s10434-025-17265-1. PMCID: 6551418.
    PubMed ID: 40348928
  • Antoniv M, Huivaniuk I, Nikiforchin A, Ivanykovych T, Chorna V, Hurtado HM,...Melnitchouk N. Adoption of the Enhanced Recovery After Surgery Practices for Colorectal Procedures: A Nationwide Assessment in Ukraine. World J Surg. 49(4):814-818. doi: 10.1002/wjs.12536.
    PubMed ID: 40050042
  • Nikiforchin, A, Sardi, A, King, MC, Iugai, S, Baron, E, Lopez-Ramirez, F,...Gushchin, V. Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS/HIPEC. European Journal of Surgical Oncology. 51(5):109675. doi: 10.1016/j.ejso.2025.109675.
    PubMed ID: 40015171
  • Falla-Zuniga, LF, King, MC, Pawlikowski, K, Nikiforchin, A, Lopez-Ramirez, F, Barakat, P,...Sardi, A. ASO Visual Abstract: Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through in-Depth Interviews. ANNALS OF SURGICAL ONCOLOGY. 2025 January;32(1):257-257. doi: 10.1245/s10434-024-16163-2.
  • Antoniv M, Nikiforchin A, Sell NM, Bordeianou LG, Francone TD, Ahmed F,...Bleday R. Impact of Multi-Institutional Enhanced Recovery after Surgery Protocol Implementation on Elective Colorectal Surgery Outcomes. J Am Coll Surg. 240(2):158-166. doi: 10.1097/XCS.0000000000001202.
    PubMed ID: 39812414
  • Huivaniuk I, Kopetskyi V, Ivanykovych T, Nikiforchin A, Kizub D, Antoniv M,...Melnitchouk N. Building an Effective International Medical Evacuation Program for Ukrainian Patients With Cancer Amid Prolonged Military Conflict. JCO Glob Oncol. 10:e2400363. doi: 10.1200/GO-24-00363. PMCID: PMC11487997.
    PubMed ID: 39388657
  • Sorokin P, Kulikova S, Nikiforchin A, Ulrikh E. Impact of Various Treatment Modalities on Long-Term Quality of Life in Cervical Cancer Survivors. Cureus. 16(9):e68642. doi: 10.7759/cureus.68642. PMCID: PMC11451432.
    PubMed ID: 39371786
  • Ivanykovych, T, Kizub, D, Antoniv, M, Huivaniuk, I, Uzlova, A, Naumova, M,...Meinitchouk, N. Evaluation of cancer care in Ukraine shows good access to treatment despite wartime. The Cancer Letter. 2024 October 25;50(40).
  • Falla-Zuniga LF, King MC, Pawlikowski K, Nikiforchin A, Lopez-Ramirez F, Barakat P,...Sardi A. Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors' Perspective Through In-Depth Interviews. Ann Surg Oncol. 31(10):7122-7132. doi: 10.1245/s10434-024-15719-6. PMCID: 7471142.
    PubMed ID: 39060692
  • Falla-Zuniga, LF, Sardi, A, King, MC, Nikiforchin, A, Lopez-Ramirez, F, Barakat, P,...Diaz-Montes, T. Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery. Surgical Oncology Insight. 1(3):100073. doi: 10.1016/j.soi.2024.100073.
  • Baron, E, Wu, CC, Nikiforchin, A, Abengozar Mingorance, R, Carr, SC, Wernberg, JA, Sharma, R. Risk factors of a positive resection margin in locoregional appendix cancer and its impact on survival: The national cancer database analysis. Surgical Oncology Insight. 1(3):100072. doi: 10.1016/j.soi.2024.100072.
  • Nikiforchin A, Baron E, Wernberg JA, Sharma R. ASO Author Reflections: Shaping Paraganglioma Management from Operating Rooms to Genetic Labs. Ann Surg Oncol. 31(7):4201-4202. doi: 10.1245/s10434-024-15365-y.
    PubMed ID: 38698282
  • Sorokin P, Novozhilov M, Utkin D, Abduragimova Z, Dudina I, Nikiforchin A, Kulikova S. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial. Klin Onkol. 2024 January;38(2):126-133. doi: 10.48095/ccko2024126.
    PubMed ID: 38697821
  • Nikiforchin A, Baron E, Wernberg JA, Sharma R. Paraaortic Extra-Adrenal Paraganglioma: Challenging Robotic Resection. Ann Surg Oncol. 31(7):4197-4198. doi: 10.1245/s10434-024-15267-z. PMCID: 4291281.
    PubMed ID: 38615151
  • Kopetskyi V, Antoniv M, Yarema R, Maksymovskyi V, Chetverikova-Ovchinnik V, Kryzhevskyi V,...Nikiforchin A. Building an Efficient Peritoneal Surface Malignancies Program Despite the Lower-Middle-Income Barriers: Ukraine Experience. JCO Glob Oncol. 10:e2300432. doi: 10.1200/GO.23.00432. PMCID: PMC12494325.
    PubMed ID: 38330272
  • Nikiforchin A, Sardi A, King MC, Baron E, Lopez-Ramirez F, Falla-Zuniga LF,...Gushchin V. Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancer. Eur J Surg Oncol. 50(2):107948. doi: 10.1016/j.ejso.2023.107948.
    PubMed ID: 38183864
  • Lopez-Ramirez, F, Sardi, A, King, MC, Nikiforchin, A, Falla-Zuniga, LF, Barakat, P,...Gushchin, V. ASO Visual Abstract: Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix. ANNALS OF SURGICAL ONCOLOGY. 2024 March;31(3):1793-1794. doi: 10.1245/s10434-023-14845-x.
  • Lopez-Ramirez F, Sardi A, King MC, Nikiforchin A, Falla-Zuniga LF, Barakat P,...Gushchin V. Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix. Ann Surg Oncol. 2024 March;31(3):1773-1782. doi: 10.1245/s10434-023-14683-x. PMCID: 9418812.
    PubMed ID: 38153641
  • Nikiforchin, A, Sardi, A, King, MC, Baron, E, Lopez-Ramirez, F, Falla-Zuniga, LF,...Gushchin, V. ASO Visual Abstract: Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. ANNALS OF SURGICAL ONCOLOGY. 2023 November;30(12):7874-7875. doi: 10.1245/s10434-023-14236-2.
  • Nikiforchin A, Sardi A, King MC, Baron E, Lopez-Ramirez F, Falla-Zuniga LF,...Gushchin V. Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 30(12):7848-7857. doi: 10.1245/s10434-023-14145-4. PMCID: 7170006.
    PubMed ID: 37633853
  • Nikiforchin A, Sardi A, King MC, Gushchin V. ASO Author Reflections: Let's Redouble Efforts to Stop Peritoneal Recurrence in All Types of Appendix Cancer. Ann Surg Oncol. 30(12):7865-7866. doi: 10.1245/s10434-023-14160-5. PMCID: 7170006.
    PubMed ID: 37624519
  • Avramov, AA, Ivanov, EV, Melekhov, AV, Menzulin, RS, Nikiforchin, AI. Risk Factors for COVID-19 Adverse Outcomes in ICU Settings of Various Types Repurposed Hospitals. General Reanimatology. 19(3):20-27. doi: 10.15360/1813-9779-2023-3-20-27.
  • Lopez-Ramirez F, Sardi A, Studeman K, King MC, Falla-Zuniga LF, Nikiforchin A,...Diaz-Montes T. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma. Eur J Surg Oncol. 49(8):1495-1503. doi: 10.1016/j.ejso.2023.03.230.
    PubMed ID: 37068984
  • Nikiforchin, A, Sardi, A, King, MC, Baron, E, Lopez-Ramirez, F, Nieroda, C, Gushchin, V. ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC—A Propensity Score-Matched Study. ANNALS OF SURGICAL ONCOLOGY. 2023 April;30(4):2531-2531. doi: 10.1245/s10434-022-12918-x.
  • Nikiforchin A, Sardi A, King MC, Gushchin V. ASO Author Reflections: Should I Stay or Should I Go? Nephrectomy for Complete CRS/HIPEC. Ann Surg Oncol. 30(4):2529-2530. doi: 10.1245/s10434-022-12956-5.
    PubMed ID: 36525210
  • Nikiforchin A, Sardi A, King MC, Baron E, Lopez-Ramirez F, Nieroda C, Gushchin V. Safety of Nephrectomy Performed During CRS/HIPEC: A Propensity Score-Matched Study. Ann Surg Oncol. 30(4):2520-2528. doi: 10.1245/s10434-022-12862-w. PMCID: 7141119.
    PubMed ID: 36463354
  • Baron E, Sardi A, King MC, Nikiforchin A, Lopez-Ramirez F, Nieroda C,...Ledakis P. Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2023 January;49(1):179-187. doi: 10.1016/j.ejso.2022.08.022.
    PubMed ID: 36253240
  • Baron, E, Sardi, A, King, MC, Nikiforchin, A, Lopez-Ramirez, F, Nieroda, C,...Ledakis, P. ASO Visual Abstract: Systemic Chemotherapy in High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread after Unsuccessful Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). ANNALS OF SURGICAL ONCOLOGY. 29(11):6592-6592. doi: doi.org/10.1245/s10434-022-11962-x .
  • Baron, E, Sardi, A, King, MC, Nikiforchin, A, Lopez-Ramirez, F, Nieroda, C,...Ledakis, P. ASO Visual Abstract: Systemic Chemotherapy in High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread after Unsuccessful Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). ANNALS OF SURGICAL ONCOLOGY. 29(11):6592-6592. doi: 10.1245/s10434-022-11962-x .
  • Baron E, Sardi A, King MC, Nikiforchin A, Lopez-Ramirez F, Nieroda C,...Ledakis P. Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC. Ann Surg Oncol. 29(11):6581-6589. doi: 10.1245/s10434-022-11894-6.
    PubMed ID: 35641710
  • Lopez-Ramirez F, Gushchin V, Sittig M, King MC, Baron E, Nikiforchin A,...Sardi A. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix. Ann Surg Oncol. 29(6):3390-3401. doi: 10.1245/s10434-021-11233-1. PMCID: 5783693.
    PubMed ID: 35133518
  • Lopez-Ramirez, F, Gushchin, V, Sittig, M, King, MC, Baron, E, Nikiforchin, A,...Sardi, A. ASO Visual Abstract: Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix. ANNALS OF SURGICAL ONCOLOGY. 29(6):3404-3404. doi: 10.1245/s10434-021-11257-7.
  • Nikiforchin A, Gushchin V, Sittig M, Baron E, Lopez-Ramirez F, Nieroda C, Sardi A. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases. Ann Surg Oncol. 29(2):873-882. doi: 10.1245/s10434-021-10669-9.
    PubMed ID: 34546479
  • Nikiforchin A, Sittig M, Gushchin V, Sardi A. ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC. Ann Surg Oncol. 29(2):883-884. doi: 10.1245/s10434-021-10824-2.
    PubMed ID: 34537898
  • Nikiforchin, A, Gushchin, V, Sittig, M, Baron, E, Lopez-Ramirez, F, Nieroda, C, Sardi, A. ASO Visual Abstract: Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy With and Without Diaphragmatic Resection in Patients with Peritoneal Metastases. ANNALS OF SURGICAL ONCOLOGY. 28(S3):722-723. doi: 10.1245/s10434-021-10740-5.
  • Nikiforchin A, King MC, Gushchin V, Sardi A. ASO Author Reflections: Pleural Spread of Peritoneal Malignancies: When Heated Chemoperfusion Can Save the Day. Ann Surg Oncol. 28(13):9136-9137. doi: 10.1245/s10434-021-10329-y. PMCID: 3357938.
    PubMed ID: 34313886
  • Oganesyan A, Menzulin R, Surovoy Y, Nikiforchin A, Zykov K. Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients. Crit Care Res Pract. 2021 July;2021:5557302. doi: 10.1155/2021/5557302. PMCID: PMC8645403.
    PubMed ID: 34877019
  • Nikiforchin A, Gushchin V, King MC, Baron E, Lopez-Ramirez F, Sardi A. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies. Ann Surg Oncol. 28(13):9126-9135. doi: 10.1245/s10434-021-10298-2. PMCID: 6448431.
    PubMed ID: 34263367
  • Nikiforchin, A, Gushchin, V, King, MC, Baron, E, Lopez-Ramirez, F, Sardi, A. ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients With Intrapleural Dissemination of Peritoneal Surface Malignancies. ANNALS OF SURGICAL ONCOLOGY. 28(S3):519-519. doi: 10.1245/s10434-021-10344-z.
  • Sorokin P, Nikiforchin A, Dubinin A. Aorta Tetrafurcation. J Minim Invasive Gynecol. 28(10):1667-1668. doi: 10.1016/j.jmig.2021.04.015.
    PubMed ID: 33933658
  • Baron E, Velez-Mejia C, Sittig M, Spiliotis J, Nikiforchin A, Lopez-Ramirez F,...Sardi A. Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C. Eur J Surg Oncol. 47(9):2352-2357. doi: 10.1016/j.ejso.2021.04.002.
    PubMed ID: 33933342
  • Nikiforchin A, Gushchin V, King MC, Baron E, Nieroda C, Sittig M, Sardi A. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol. 123(4):1030-1044. doi: 10.1002/jso.26371.
    PubMed ID: 33524164
  • Baron E, Gushchin V, King MC, Nikiforchin A, Sardi A. Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review. Case Rep Oncol Med. 2020 October;2020:8853704. doi: 10.1155/2020/8853704. PMCID: PMC7584972.
    PubMed ID: 33123396
  • Sorokin P, Nikiforchin A, Panin A, Zhukov A, Gushchin V, Kurtser M. Diffuse Ectopic Deciduosis Imitating Peritoneal Carcinomatosis with Acute Abdomen Presentation: A Case Report and Literature Review. Case Rep Obstet Gynecol. 2020 September;2020:8847082. doi: 10.1155/2020/8847082. PMCID: PMC7533791.
    PubMed ID: 33062356
  • Baron E, Gushchin V, King MC, Nikiforchin A, Sardi A. Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 27(13):4931-4940. doi: 10.1245/s10434-020-08479-6. PMCID: 8849962.
    PubMed ID: 32506191
  • Nikiforchin A, Gushchin V, King MC, Sardi A. ASO Author Reflections: Not All Low-Grade Appendiceal Mucinous Neoplasm Mucin is Created Equal. Ann Surg Oncol. 27(13):4918-4919. doi: 10.1245/s10434-020-08604-5.
    PubMed ID: 32436189
  • Nikiforchin A, King MC, Baron E, MacDonald R, Sittig M, Nieroda C,...Sardi A. Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 27(13):4908-4917. doi: 10.1245/s10434-020-08535-1.
    PubMed ID: 32409962
  • Nikiforchin A, Baron E, Sittig M, Gushchin V. Soft-Tissue Myoepithelioma of the Retroperitoneal Space Mimicking a Pancreatic Tumor: A Case Report and Literature Review. J Med Cases. 11(1):16-21. doi: 10.14740/jmc3407. PMCID: PMC8383676.
    PubMed ID: 34434330
  • Nikiforchin A, Peng R, Sittig M, Kotiah S. A Rare Case of Metastatic Heterogeneous Poorly Differentiated Neuroendocrine Carcinoma of Ileum: A Case Report and Literature Review. J Med Cases. 11(1):6-11. doi: 10.14740/jmc3401. PMCID: PMC8383677.
    PubMed ID: 34434328